What diseases can mitotane treat?

Mitotan is widely accepted for the treatment of advanced adrenocortical cancer. Mitotane provides an effective treatment option for patients who are inoperable or who develop local recurrence and metastasis after surgery. Although current research shows that its overall effectiveness is approximately 24%, in clinical practice, mitotane is still regarded as an important treatment option for patients with this type of cancer. Its mechanism of action is mainly by inhibiting the function of the adrenal cortex. Specifically, mitotane can intervene in the mitochondria of the zona fasciculata and zona reticularis cells of the adrenal cortex, thereby reducing the synthesis and secretion of hormones such as cortisol and androgens, ultimately leading to tumor shrinkage and alleviation of symptoms related to functional cortical cancer.

In addition to its use in adrenocortical cancer, mitotane also plays an important role in the treatment of Cushing's syndrome. Cushing's syndrome is an endocrine disorder caused by excess glucocorticoids in the body, and is often accompanied by a series of clinical manifestations, such as obesity, hypertension, diabetes, etc. Mitotane effectively reduces the synthesis and release of glucocorticoids by inhibiting the cortical function of the adrenal gland, thereby helping to control the patient's symptoms. Mitotane has become an important treatment option for patients with Cushing's syndrome who are inoperable or have poor outcomes after surgery. Multiple case reports have demonstrated significant improvements in symptom control and quality of life in patients taking long-term mitotane.

During treatment with mitotane, doctors will monitor patients closely to evaluate changes in symptoms, fluctuations in hormone levels, and possible adverse reactions. This kind of monitoring not only helps to detect problems in time, but also adjusts treatment plans based on the patient's specific situation to ensure efficacy and safety. Doctors will flexibly adjust the dosage and medication regimen of mitotane based on the patient's physical response, striving to achieve the best therapeutic effect.

References:

https://www.mayoclinic.org/drugs-supplements/mitotane-oral-route/description/drg-20064841

xa0